30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

NOVAGALI PHARMA

Top insiders
Trades
EDMOND DE ROTHSCHILD INVESTMENT PARTNERS
agissant pour le compte de fonds dont elle assure la gestion, Membre du Conseil de Surveillance
1 sale — total 15,644,831 EUR
Sale 11 Oct 2011
Value €356,470.58 | Price 442.05 | Shares 85,858
Sale 11 Oct 2011
Value €3,170,777.58 | Price 308.70 | Shares 54,355
Through IdInvest Partners, a closely affiliated person
Sale 11 Oct 2011
Value €161,203.80 | Price 6.15 | Shares 26,212
Sale 11 Oct 2011
Value €167,575.20 | Price 6.15 | Shares 27,248
Sale 11 Oct 2011
Value €2,121,239.55 | Price 6.15 | Shares 344,917
Sale 11 Oct 2011
Value €7,330,234.20 | Price 6.15 | Shares 1,191,908
Sale 11 Oct 2011
Value €13,713,171.60 | Price 6.15 | Shares 2,229,784
Sale 11 Oct 2011
Value €43,542.00 | Price 6.15 | Shares 7,080
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2011-10-20 2011-10-11 S Sale EDMOND DE ROTHSCHILD INVESTMENT PARTNERS

agissant pour le compte de fonds dont elle assure la gestion, Membre du Conseil de Surveillance

Supervisory Board Member
85,858
442.05
€356,471
85,858 442.05 €356,471
2011-10-20 2011-10-11 S Sale Kurma Life Sciences Partners

agissant pour le compte de fonds dont elle assure la gestion, Membre du Conseil de Surveillance

Through IdInvest Partners, a closely affiliated person Supervisory Board Member
54,355
308.70
€3,170,778
54,355 308.70 €3,170,778
2011-10-20 2011-10-11 S Sale

Président du Directoire

Management Board Member
71,200
441.26
€3,122,126
71,200 441.26 €3,122,126
2011-10-20 2011-10-11 S Sale

Membre du Conseil de Surveillance

Supervisory Board Member
27,248
6.15
€167,575
27,248 6.15 €167,575
2011-10-20 2011-10-11 S Sale

Membre du Conseil de Surveillance

Supervisory Board Member
344,917
6.15
€2,121,240
344,917 6.15 €2,121,240
2011-10-20 2011-10-11 S Sale CDC INNOVATION

agissant pour le compte de fonds dont elle assure la gestion, en qualité de Censeur du Conseil de Surveillance

Supervisory Board Member
1,191,908
6.15
€7,330,234
1,191,908 6.15 €7,330,234
2011-10-20 2011-10-11 S Sale AURIGA PARTNERS

agissant pour le compte de fonds dont elle assure la gestion, Membre du Conseil de Surveillance

Supervisory Board Member
2,229,784
6.15
€13,713,172
2,229,784 6.15 €13,713,172
2011-10-20 2011-10-11 S Sale

Membre du Conseil de Surveillance

Supervisory Board Member
7,080
6.15
€43,542
7,080 6.15 €43,542
Explore more

More insider trading research around NOVAGALI PHARMA